Hyperemesis Gravidarum

Hyperemesis Gravidarum

Debra K. Gardner, Pharm.D.
Specialty Practice Pharmacist, Women & Infants, Department of Pharmacy, Ohio State University Medical Center, Columbus, OH

Nausea and vomiting have been associated with early pregnancy since the beginning of time. Nausea and vomiting in pregnancy were documented in a physician’s papyrus dated 2000 B.C. and discussed in Soranus’ Gynaecology, a medical text from the second century A.D.1 Although nausea and vomiting are common complaints of pregnancy (50% to 90% of all pregnant women have "morning sickness"), much remains unknown about its pathophysiology, and there is no universally agreed upon therapy. Even today, women are told to grin and bear it until symptoms abate after the first trimester.

An extreme form of pregnancy-induced vomiting is hyperemesis gravidarum (HG). HG is defined as intractable vomiting in pregnancy that causes dehydration, electrolyte disturbances, nutritional deficiencies and weight loss. Before intravenous fluid therapy was available, hyperemesis was a major cause of maternal mortality. In fact, therapeutic abortion was introduced in 1813 as a treatment of hyperemesis gravidarum.1 Charlotte Bronte, the famous 19th century author of Jane Eyre, died of hyperemesis in 1855 in her fourth month of pregnancy.2

Vomiting has been reported in 56% of all pregnant women.2 Hyperemesis gravidarum, however, occurs in 3.5 per 1,000 pregnancies.1,3,4 It is more common in urban than in rural populations and it is very rare in native American, Eskimo, African and Asian communities.1 In affected populations, it is more common in women who weigh more than 170 pounds, are nonsmokers, have twin pregnancies, trophoblastic disease and are less than 20 years old.1 Hyperemesis is most common in first pregnancies and tends to recur in subsequent pregnancies. Epidemiological studies indicate that women with nausea and vomiting in pregnancy have a statistically significant decreased risk of miscarriage in the first 20 weeks.2

Fortunately, most studies do not indicate any deleterious effects of HG on the fetus unless weight gain continues to be poor during the second half of pregnancy.5 Poor maternal weight gain increases the risk of delivery of a low-birth-weight infant and associated neurodevelopmental sequelae.6


The cause of hyperemesis gravidarum is unknown, and there are many theories as to its etiology. HG has been described as the "disease of theories" and it is probably multifactorial in origin. Pathophysiologic theories include endocrine, psychological or autonomic nervous system dysfunction, gastric dysrhythmia and nutritional deficiencies.2

Throughout history, psychogenic reasons have been thought to contribute to the pathogenesis of HG. Hyperemesis was thought to represent a somatic expression of psychological conflict or psychiatric illness exacerbated by pregnancy.1 A number of studies support this theory, including one indicating that up to 70% of hyperemetic women respond to some degree to placebo.1 In addition, hyperemesis only occurs in human pregnancies, is treatable by hypnosis, and decreases in incidence during wartime and in times of famine.1 Contrary to this theory, many studies have found no difference in the incidence of psychological disorders in women with and without HG.

Gestational hormones have long been thought to contribute to hyperemesis. Some researchers have found serum hCG (human chorionic gonadotropin) levels to be higher in hyperemetic women than in normal pregnant controls.1 High levels of estrogen may play a role, since women who suffer nausea and vomiting while taking oral contraceptives are more likely to have hyperemesis when pregnant. Progesterone may contribute, since it prolongs gastric emptying time and decreases smooth muscle motility. However, no difference in estrogen or progesterone levels has been found in women with HG.

Transient elevations in serum thyroxine levels, especially the serum level of free thyroxine, have been documented in as many as 70% of pregnancies complicated by HG.7 This hyperthyroid state is usually without significant symptoms and resolves spontaneously without treatment at the same time that HG resolves. The pathogenesis of the hyperthyroid is not completely understood, although some authors believe that hCG or some variant of hCG is responsible. HG usually occurs in the first trimester when levels of hCG are high and peak levels of hCG have an inherent thyroid-stimulating effect equivalent to 3–10 µU/mL.7

A recent theory of the pathogenesis of HG cites a dysfunctional gastric pacesetter as the core of the problem.3,8-11 This dysfunction is characterized by reversed gastroduodenal peristaltic waves, resulting in regurgitation of duodenal content into the stomach and subsequent nausea and vomiting. The retrograde gastric contractions result in reflux of gastric contents into the esophagus even in the absence of food. This is more pronounced during the liquid phase than the solid phase of gastric emptying, and is thought to be due to maladaptation of the GI tract to gestational hormones. When adaptation occurs by the end of the first trimester, gastric motility resumes and hyperemesis ceases.

Another theory attributes HG to deficiencies of nutrients such as pyridoxine and zinc deficiencies. However, controlled studies have failed to show a difference in the levels of these nutrients in women with hyperemesis.2 Sahakian et al. demonstrated in a double-blind, placebo-controlled study of 59 hyperemetic pregnant women that pyridoxine 25 mg every 8 hours significantly reduced vomiting.12

Clinical Characteristics

Hyperemesis gravidarum begins between the fourth and sixth week of pregnancy, often before the woman realizes she is pregnant. Symptoms usually improve by the 15th to 20th week of gestation, although some women continue to have frequent relapses throughout pregnancy. Most affected women have numerous episodes of vomiting throughout the day without symptom-free periods. This leads to weight loss, dehydration, electrolyte disturbances, ketosis and acetonuria requiring hospitalization. If these derangements are not treated promptly, they can lead to renal and hepatic damage. Other complications include Mallory-Weiss tears (linear mucosal tears at the cardio-esophageal junction with hematemesis), acid aspiration and metabolic alkalosis. These women present to their physicians with weight loss of five to 20 pounds; however, since many are overweight to begin with, they may not appear malnourished on visual inspection. Ptyalism, or excessive salivation, often accompanies HG, and some women require an emesis basin to expectorate into.

Laboratory findings at the time of presentation include increased ketones and increased urine specific gravity associated with an increased blood urea nitrogen. There is often an increased hematocrit, indicating a contracted blood volume. Electrolyte derangements include decreased sodium, potassium, chloride and magnesium levels. In some patients tests reveal an increase in liver function, such as in aspartate aminotransferase, alanine aminotransferase or bilirubin activity.2 If the woman has been unable to eat for a prolonged period of time, vitamin deficiencies can occur and Wernicke’s encephalopathy (an inflammatory, hemorrhagic form of encephalopathy caused by thiamine deficiency and usually associated with chronic alcoholism) has been reported.13

Other causes of nausea and vomiting unrelated to pregnancy, such as gastroenteritis, must be ruled out before the diagnosis of hyperemesis can be made. Conditions such as diabetic gastroparesis, peptic ulcer disease, gall bladder disease, hepatitis, renal dysfunction, hypercalcemia and hyperparathyroidism can all be associated with nausea and vomiting.


Reassurance and counseling are important components of therapy. Because patients are often frustrated and depressed, it is helpful for them to gain a better understanding of their disease and realize that they are not the only the only ones to suffer from HG. A patient education pamphlet designed to answer patients’ questions is recommended (FIGURE 1). A diary of times of the day when vomiting occurs and common triggers, such as foods, odors and activities or events, is beneficial. Patients who are particularly withdrawn or difficult to communicate with may require a psychologic consultation. Some authors have advocated treatment of hyperemesis with behavioral therapy, using stimulus control and imaging procedures.14

Figure 1.
Hyperemesis Gravidarum: Patient Education


Over half of all pregnant women will experience some nausea and vomiting during the first three months of pregnancy. This is often called morning sickness, but it can occur at any time of the day.

A few women (about 4 in every 1,000 pregnant women) can develop the condition called hyperemesis gravidarum (HG). This is when the vomiting becomes so frequent and severe that the woman loses a large amount of weight. This can result in not enough water in the body (dehydration) and the body may not get enough nutrients to function properly. If HG becomes severe, it can be dangerous for both the mother and the baby.

What Causes Hyperemesis Gravidarum?

The cause of HG is not completely understood, but there are several factors that seem to contribute to it:

  • Rapidly changing hormone levels during early pregnancy
  • The physical and emotional stress of pregnancy on the body
  • Food in the stomach empties more slowly
  • Stomach contents may move backwards into the esophagus (the tube that goes from the mouth to the stomach)
  • Lack of certain vitamins

How Can I Tell if I Have Morning Sickness or HG?

Call your doctor if you have the following symptoms of HG:

  • Weight loss, usually 5 to 10 pounds or more
  • You cannot keep any food or fluids down for over 24 hours
  • Your urine becomes very dark yellow, or you do not urinate for long periods
  • You have abdominal pain, fever, severe weakness, or feel faint

How Can Hyperemesis Gravidarum Be Treated?
There are several treatments for HG that are usually done in the following order:

1. Dietary Changes

  • Eat small frequent meals to avoid having an empty stomach. Eat dry crackers, toast, or cereal before getting out of bed or when feeling queasy or nauseated.
  • Drink lots of water between meals, but not during meals. Wait at least 30 minutes after eating before drinking fluids.
  • Eat foods that are easy to digest such as toast, crackers, bagels, pretzels, cereal, rice, pasta, and potatoes.
  • Avoid greasy or spicy foods
  • Avoid strong food smells

2. Keep a Diary

  • Keep a diary of when vomiting occurs and anything that triggers it, such as certain foods, odors, activities, or places. This information can help both you and your doctor.

3. Medical Treatment

  • If severe dehydration occurs, intravenous fluids (by vein) may need to be given.
  • Many doctors prefer not to give any medicines during pregnancy, if possible. However, in this situation the risk of using certain medicines is much less than the risk of malnutrition and weight loss from HG. The following medicines have been used for years and are known not to harm the baby. Your doctor may prescribe some of these medicines.

Patient education materials describing how these drugs work and possible side effects are available for each of the listed medicines. Make sure your doctor, pharmacist or nurse reviews these medicines with you.

Over-the-Counter Medicines
(purchased without a prescription):
Medicines for nausea and motion sickness Antihistamines
Meclizine (Bonine, Antivert)
Dimenhydrinate (Dramamine)
Diphenhydramine (Benadryl)
Doxylamine (Unisom tablets)
Pyridoxine (Vitamin B6)

Prescription Medicines

Phenothiazines: to treat nausea and vomiting
Prochlorperazine (Compazine)
Promethazine (Phenergan)
Chlorpromazine (Thorazine)
Medicines to increase the movement of food from the stomach to the intestines
Metoclopramide (Reglan)
Medicines to decrease stomach acid production and treat reflux, or movement of stomach contents backwards into the esophagus
Ranitidine (Zantac)
Famotidine (Pepcid)
Cimetidine (Tagamet)
Copyright 1997, The Ohio State University Medical Center Department of Consumer & Health Education & Wellness

For the woman who is dehydrated, correction of fluid and electrolyte disturbances is imperative. Intravenous fluids such as 5% dextrose in lactated Ringers solution will provide electrolytes. Multivitamins should be added once a day if available. If IV multivitamins are not available, thiamine and pyridoxine should be added. Many patients stop vomiting once they are rehydrated.

When vomiting has ceased for 24 hours, a diet of dry foods should be introduced. Small, frequent meals to avoid being either too hungry or too full may be effective. High carbohydrate foods, such as baked potatoes, crackers, breads, rice and pasta are best tolerated.4 These foods also contain essential B vitamins. Fatty foods should be avoided, as they slow gastric emptying. The patient should wait about 30 minutes after eating before drinking fluids. Avoidance of offensive food odors helps some women. Consulting a dietitian is helpful in difficult cases to ensure proper nutritional intake.

It may be helpful to omit prenatal vitamins with iron because they can cause considerable nausea. Some women can tolerate children’s chewable vitamins better.

For patients who fail to respond to fluids alone, pharmacologic therapy may be necessary. Many physicians are reluctant to use drugs in the first trimester since organogenesis occurs during this period. However, several medications have been prescribed for HG for decades and are known to be safe in pregnancy (TABLE 1).

Table 1.
Drug Therapy of Hyperemesis Gravidarum
Drug (generic/brand) Dose and Route Adverse Effects Monitoring Parameters/
Depress hyperstimulated labyrinth apparatus. Block acetylcholine receptors in vestibular center. Antiemetic action may be mediated through nerve pathways to the vomiting center from the CTZ, peripheral nerve pathways, or other CNS centers.
(Bonine, Antivert)
25 mg PO Q 8 hr Drowsiness most common, dry mouth, blurred vision, constipation, urinary retention Long duration of action, may last up to 24 hr
50–100 mg Q 4-6 hr   Chlorotheophylline salt of diphenhydramine
25 mg PO Q HS,
1/2 tablet Q 6 hr PRN
  Component of Bendectin
25 mg IVP/PO Q 4–6 hr    
25 mg PO Q 6–8 hr
200 mg rectally or IM Q 6–8 hr
  Suppositories available
(Vistaril, Atarax)
25 mg PO q 6 hr   Syrup available
Block postsynaptic dopamine receptors in hypothalamus and limbic system. Act on D1 & D2 receptors in CTZ.
5–10 mg PO, IM, or IV Q 6–8 hr
Rectal 25 mg Q 6–8 hr
Drowsiness, hypotension, dry mouth, constipation, urinary retention

Rash Extrapyramidal symptoms (EPS):

  • dystonic reactions
  • torticollis
  • pseudoparkinsonism
  • akathesia
Risk of EPS additive with metoclopramide. Treat EPS sx with Benadryl (can prophylax with Benadryl) Phenothiazines lower seizure threshold
12.5–25 mg IVP/PO IM/
per rectum Q 4-6 hr
12.5–25 PO/IM Q 4–6 hr
Rectal 50–100 mg Q 6–8 hr
  May increase risk of malformations
1–2 mg PO/IM Q 8 hr   EPS sx more common
H2 antagonists
Competitively inhibit action of histamine on the H2 receptors of parietal cells, reducing gastric acid secretion. Basal gastric acid secretion is inhibited moreso than meal-stimulated acid secretion.
50 mg IV Q 8 hr or
150 mg PO BID
Headache, dizziness Must give IV piggyback
20 mg IVP/PO q 12 hr Headache Can be given IV push
Reglan blocks dopamine receptors in the CTZ and increases the CTZ threshold & decreases the sensitivity of visceral nerves that transmit afferent impulses from the GI tract to the VC. Peripheral antiemetic enhanced gastric emptying.
10–20 mg IV/PO Q 6 hr Drowsiness, dizziness, diarrhea, restlessness, EPS Additive CNS side effects with phenothiazines
10 mg PO QID, ac & hs
(maximum dose 20 mg QID)
Diarrhea, abdominal pain No CNS side effects
Highly selective antagonist of 5-HT3 receptors in the vagus, CTZ and gut.
8 mg IV/PO Q 8 hr until vomiting stops Headache, liver function abnormalities, constipation, diarrhea, sedation Discontinue as soon as vomiting stops
Very costly
Two case reports in pregnancy
(Vitamin B
50 mg/day Paresthesias  
Ginger 250 mg PO QID or glass of ginger ale PRN None known Has been used for centuries

NOTE: Antispasmodics and antimuscarinics, such as scopolamine and belladonna tincture, and Emetrol, an OTC treatment, should not be used in treatment of hyperemesis gravidarum.

* Recommended therapy at Ohio State University Medical Center

Certain antihistamines, such as meclizine (Antivert), dimenhydrinate (Dramamine) and its active moiety diphenhydramine (Benadryl) are very effective antiemetics. (Benadryl is our first choice because it can be administered by IV, PO and IM.) These agents antagonize the central action of acetylcholine and decrease stimuli going to the chemoreceptor trigger zone (CTZ) and vomiting center. Bendectin, the only drug ever approved by the U.S. Food and Drug Administration for morning sickness, originally contained the antihistamine doxylamine, the antispasmodic dicyclomine and vitamin B6.

Dicyclomine was removed from the formulation in 1976, when clinical trials failed to show evidence of its benefits as a synergistic antiemetic. Millions of women were prescribed this agent and found that it relieved nausea and vomiting. However, in 1979 The National Enquirer broke a scandalous and untrue front page news story about a drug company "cover-up" of several thousand tragically deformed infants in the U.S.15 As a result of this story, lawyers began advertising in women’s magazines advising mothers of malformed children to sue Merrell Dow if they had taken Bendectin during their pregnancy. The March of Dimes received thousands of phone calls from women who had been advised to have abortions as a result of having taken Bendectin. In 1983 Merrell Dow removed Bendectin from the market when legal costs surpassed the income from the drug. Evidence is clearer today than in 1983 that Bendectin does not cause birth defects. In 1983, the editor of the medical journal Teratology called Bendectin the "most famous tortogen/litogen and best- studied human non-teratogen."16

A recently published meta-analysis of epidemiological studies found that Bendectin exposure does not increase the prevalence of congenital malformations.17 This tragedy demonstrates how false and distorted information published in tabloid journals can affect medical practice, and these events will probably prevent any drug from being approved by the FDA for nausea and vomiting in pregnancy.

Doxylamine, one of the components of Bendectin, is available today in the over-the-counter sleep aid Unisom tablets. It does carry a warning on the package against its use in pregnancy and this should be explained to the pregnant women if it is recommended as an antiemetic.

Antispasmodics such as scopolamine are often used to treat motion sickness. However, these agents slow gastric emptying and prolong GI transit time. Since slowed gastric emptying is part of the etiology of HG, these agents are inappropriate for its treatment.

The phenothiazines promethazine (Phenergan) and prochlorperazine (Compazine) are effective antiemetics that work by central antagonism of dopamine in the CTZ. There is no increased risk of congenital malformations from phenothi-azines.18 Young women are particularly susceptible to dystonic reactions and extrapyramidal side effects caused by these agents; however, antihistamines such as diphenhydramine prophylax against these side effects. Therefore, it is important to include an antihistamine with the phenothiazines not only for their antiemetic action, but to prevent adverse drug reactions.

Metoclopramide (Reglan) increases lower esophageal sphincter pressure, decreasing gastroesophageal reflux. It accelerates gastric emptying and acts directly on the CTZ. Like the phenothiazines, metoclopramide can cause dystonic reactions and extrapyramidal side effects; thus, it also requires concomitant administration of an antihistamine to counteract these effects. Cisapride (Propulsid) is another prokinetic agent which stimulates motor activity in the GI tract by enhancing the release of acetylcholine from the enteric nervous system. However, a lack of published studies on its use in pregnancy and the fact that it is assigned a pregnancy category C (see sidebar), make its use in HG controversial. Cisapride may have an advantage over metoclopramide in that it does not cause dystonic or extrapyramidal reactions.

Histamine-2 blockers such as ranitidine (Zantac) are also useful in gastroesophageal reflux that occurs in HG. They reduce gastric acid production by competitive blockade of H2 receptors in gastric parietal cells. These agents provide symptomatic relief of heartburn. Ranitidine, cimetidine (Tagamet), and famotidine (Pepcid) all are assigned pregnancy category B (see sidebar).

Ondansetron (Zofran) is a selective serotonin-3 receptor antagonist usually reserved for the most highly emetogenic cancer chemotherapy due to its extremely high cost. Published literature for its use in pregnancy is limited to a few case reports and one small study; therefore, it is considered a last-line agent in HG when all other pharmacologic therapy has failed.19-22 Sullivan et al. randomized 30 women with HG to receive either IV ondan-setron or promethazine in a double-blind design. They found no difference in relief of nausea, weight gain or length of hospitalization between the two drugs.22

For patients with severe malnutrition in whom pharmacologic therapy has failed, tube feedings or total parenteral nutrition (TPN) may be necessary.23,24 Many authors have advocated iso-osmolar tube feeding by a small-bore nasogastric feeding tube.25-27 Risks with this method include tube displacement and pulmonary aspiration and experience at our institution shows poor patient acceptance. Many physicians initiate home TPN without having first attempted an adequate trial of anti-emetic medications and fail to realize the serious risks involved. Life-threatening complications of catheter insertion such as pericardial tamponade, pneumothorax and subclavian artery laceration have been described in the nutrition and surgical literature.15 Metabolic and infectious complications of parenteral nutrition are not uncommon. Pregnant women receiving home TPN have been admitted to our hospital in Gram-negative septic shock, with severe cellulitis requiring surgery, and hyperglycemia. TPN should be reserved for hyperemetic women only when medical management has failed an adequate trial and the patient is severely malnourished.

Nonpharmacologic Therapy

Despite counseling and discussion of the risks and benefits of HG and pharmacologic therapy, some women refuse to take any drugs during pregnancy. For these women interventions may include dietary and lifestyle changes (TABLE 2). Alternative therapies include ginger and herbal teas. Fisher-Rasmussen et al. conducted a double-blind placebo controlled crossover study of powdered ginger root for HG.28 Capsules containing 250 mg ginger or placebo were given to 30 women four times a day for four days. After a two-day washout the groups switched for four more days. The powdered ginger root provided more significant relief of vomiting than placebo.28 Ginger ale may be a more acceptable and readily available form of ginger and the carbonation may be helpful. Herbal teas that have been promoted for nausea and vomiting include raspberry leaf tea and chamomile tea.4

Table 2.
Nonpharmacologic Interventions for Hyperemesis Gravidarum

Eat small amounts of food every 2–3 hours

Eat low-fat complex carbohydrates

  • rice
  • pasta
  • potatoes
  • bread
  • cereal
  • oatmeal

Eat low-fat protein foods

  • lean meat
  • broiled or canned fish
  • boiled beans
  • eggs
  • poultry without the skin

Eat fruit and drink fruit juices

Drink soups and other liquids between meals rather than with meals

Avoid greasy or fried foods, as they are hard to digest

Eat lightly seasoned foods, but salt to taste to replace electrolytes

Sit upright after meals to reduce gastric reflux

Eat a snack before going to bed or during the night, such as

  • yogurt
  • milk
  • juice
  • bread
  • small sandwich

Eat a piece of bread or cracker before getting out of bed in the morning

Get out of bed slowly. Avoid sudden movements

Avoid brushing teeth immediately after eating

Rest as needed, with feet up and head slightly elevated

Get plenty of fresh air and light exercise

Open windows when cooking or use exhaust fan to eliminate odors

Treatment of HG in Chinese literature focuses on acupuncture. Effective points of stimulation are the P6 or Neiguan point and the ears. The Neiguan point is 5 cm from the distal wrist crease, between the tendons of the flexi carpi radialis and palmaris longus.29,30 For women who refuse to take medications during pregnancy, acupressure bracelets may be an alternative.15 These are sold in boating stores and by auto clubs to treat motion sickness. Their mechanism of action is based on acupuncture principles. They consist of an elastic band with a large plastic button on one side that is placed over the above mentioned tendons.

Pharmacist-initiated HG Protocol

Since the Ohio State University Medical Center is a large teaching hospital and a regional prenatal referral center, only patients with refractory HG are admitted to the facility. Many of these patients have lost a significant amount of weight and have been on home IV or TPN therapy. The obstetric residents would consult the TPN pharmacist to initiate parenteral nutrition if the patient had been on home TPN or was severely malnourished. When the obstetricians encountered limited success with drug therapy and adverse drug reactions (ADRs) in many patients, they began to consult the specialty practice pharmacist for women and infants. The TPN pharmacist and the women and infants’ pharmacist worked on a plan together, allowing a 24-hour trial of IV fluids and medications before TPN was instituted. If the patient stopped vomiting, a diet of dry foods was started on the second day. The obstetricians, impressed with the success of the medical therapy prescribed by the pharmacist and the ability to avoid use of TPN, invited the specialty practice pharmacist to speak at OB Grand Rounds on the treatment of HG.

The pharmacist emphasized using drugs that worked by mechanisms that would relieve the pathology of HG and discouraged those that would aggravate the condition, such as scopolamine. Medications with established safety in pregnancy that work synergistically and avoided side effects were stressed. The risks of TPN therapy were reviewed, and TPN was advised to be used only as a last resort, when pharmacologic therapy fails. As a result of the Grand Rounds presentation, a cost-effective protocol was developed for treating patients with HG, which included counseling and written patient education (FIGURE 1). Drug therapy included diphenhydramine 25 mg, promethazine 12.5 mg, metoclopramide 10 mg, and ranitidine 50 mg, all administered IV push every 6 hours. Pyridoxine 50 mg was added to the maintenance IV fluid once daily. As soon as the patient stopped vomiting, all medications were switched to the oral route and a diet of dry foods was ordered, generally beginning with a baked potato. When caloric intake was sufficient, the patient was discharged on the same four-drug regimen.

The first 12 patients entered on the pharmacist-initiated HG protocol were compared to the previous 17 patients treated by the obstetric service. The average weight loss was 17.8 pounds in the protocol group and 15.8 pounds in the standard therapy group. Three patients in the protocol group and only one patient in the standard group were hyperthyroid. The protocol proved very effective, since eight of 12 patients stopped vomiting within 24 hours of entering the hospital. The remaining four patients stopped vomiting by 48 hours. Only four of 17 patients in the standard group stopped vomiting within 24 hours.

While the only complaint in the HG protocol group was drowsiness, there were three adverse drug reactions in the other group. Most adverse reactions were due to concomitant administration of more than one phenothiazine, producing dystonic reactions. Six patients in the protocol group were on home TPN at the time they entered the hospital. TPN was able to be discontinued in all of the protocol patients within one day of admission, whereas the five patients in the standard group were kept on prolonged TPN therapy.

The pharmacist-initiated HG protocol provided rational, effective therapy that generally relieved vomiting within 24 hours. This combination of medications prevented adverse drug reactions. The medications were administered by IV push, the least expensive method. Home medications were always given orally, or by rectal suppository when vomiting prevented use of the oral route, rather than by expensive and risky methods, such as the metoclopramide continuous IV pump.


Although nausea and vomiting are common complaints during pregnancy, hyperemesis gravidarum is more rare, occurring in 3.5 per 1,000 pregnancies. The pathophysiology of HG is not completely understood, but likely involves a maladaptation of the gastrointestinal tract to gestational hormones, causing gastric reflux and retrograde peristalsis. There may also be a psychogenic component.

Treatment should involve counseling, administration of intravenous fluids and electrolyte replacement. When patients fail to respond to this regimen, pharmacologic therapy should be tried before beginning TPN. A combination of an antihistamine, a phenothiazine, an H2-blocker and metoclopramide is effective and reduces the chance of dystonic reactions. A diet of small, frequent meals consisting of low-fat, high carbohydrate foods is best tolerated by these patients. Women who refuse medications may benefit from herbal teas, ginger or acupressure bracelets. HG generally resolves by 16 to 20 weeks’ gestation.

FDA-Assigned Pregnancy Categories*
Category A

Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).

Category B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

Category C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Category D

There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Category X

Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

* Excerpted from Drug Information for the Health Care Professional, USP-DI, Volume 1A, 11th ed., 1991.

1. Singer AJ, Brandt LJ. Pathophysiology of the gastrointestinal tract during pregnancy. Am J Gastroenterol. 1991;86:1695-1712. 2. Abell TL, Riely CA. Hyperemesis gravidarum. Gastroenterol Clin N Am. 1992;21:835-49. 3. Mogadam M. Perspective as to pathogenesis and management of hyperemesis in pregnancy. Am J Gastroenterol. 1992;87:806-7. 4. Newman V, Fullerton JT, Anderson PO. Clinical advances in the management of severe nausea and vomiting during pregnancy. JOGNN. 1993;22:483-90. 5. Hallak M, Tsalamandris K, Dombrowski MP, et al. Hyperemesis gravidarum: effects on fetal outcome. J Reproductive Med. 1996;41:871-4. 6. Institute of Medicine: Nutrition During Pregnancy. National Academy Press. Washington D.C. 1990 (IV). 7. Bouillon R, Naesses M, Van Assche FA, et al. Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol. 1982;143:922-6. 8. Devitt NF. Hyperemesis gravidarum: a case report suggesting new concepts and research needs. Family Practice Res J. 1991;11:279-82. 9. Koch KL, Creasy GW, Dwyer A, et al. Gastric dysrhythmias and nausea of pregnancy. Dig Dis Sci. 1987;32:917. (Abstract) 10. Dubois A. Gastric dysrhythmias: Pathophysiologic and etiologic factors. Mayo Clin Proc. 1989;64:246-50. 11. Riezzo G, Pezzolla F, Darconza G, et al. Gastric myoelectrical activity in the first trimester of pregnancy: A cutaneous electrogastrographic study. 12. Sahakisn V, Rouse D, Sipes S, et al. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: A randomized, double-blind placebo controlled study. Obstet Gynecol. 1991;78:33-6. 13. Lavin PJM, Smith D, Kori SH, et.al. Wernicke’s encephalopathy: A predictable complication of hyperemesis gravidarum. Obstet Gynecol. 1983;62:13. 14. Long MAD, Simone SS, Tucher JJ. Outpatient treatment of hyperemesis gravidarum with stimulus control and imagery procedures. J Behav Ther Exp Psych. 1986;17:105. 15. Kousen M. Treatment of nausea and vomiting in pregnancy. Am Fam Physician. 1993;48:1279-84. 16. Brent RL. Editorial comment on "teratogen update: Bendectin." Teratology. 1985;31:429-30. 17. McKeigue PM, Lamm SH, Linn S, et al. Bendectin and birth defects: A meta-analysis of the epidemiologic studies. Teratology. 1994;50:27-37. 18. Slone D, Siskind V, Heinonen OP, et al. Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol. 1977;128:486-8. 19. World MJ. Ondansetron and hyperemesis gravidarum. Lancet. 1993;341:185. 20. Guikontes E, Spantideas A, Diakakis J. Ondansetron and hyperemesis gravidarum. Lancet. 1992;340:1223. 21. Sullivan et al. IV ondansetron for hyperemesis. Am J Obstet Gynecol. 1996;174:1565-68. 22. Tincello DG, Johnstone MJ. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron. Postgrd Med J. 1996;72:688-9. 23. Charlin V, Borghesi L, Hasbun, et al. Parenteral nutrition in hyperemesis gravidarum. Nutrition. 1993;9:29-32. 24. Zibell-Frisk D, Jen KL, Rick J. Use of parenteral nutrition to maintain adequate nutritional status in hyperemesis gravidarum. J Perinatol. 1990;10:390-5. 25. Gulley RM, Vander PN, Gulley JM. Treatment of hyperemesis gravidarum with nasogastric feeding. Nutr Clin Prac. 1993;8:33-5. 26. Boyce RA. Enteral nutrition in hyperemesis gravidarum: a new development. J Am Diet Assoc. 1992;92:733-6. 27. Barclay BA. Experience with enteral nutrition in the treatment of hyperemesis gravidarum. Nutr Clin Prac. 1990;5:153-5. 28. Fischer-Rasmussen W, Kjaer SK, Dahl C, et al. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gyncol. 1991;38:19-24. 29. Dundee JW. Belfast experience with P6 acupuncture antiemesis. Ulster Med J. 1990;59:63-70. 30. Zhao CX. Acupuncture treatment of morning sickness. J Tradit Chin Med. 1988;8:228-9.